EM

Emami LtdNSE EMAMILTD Stock Report

Last reporting period 31 Mar, 2024

Updated 18 Sep, 2024

Last price

Market cap $B

3.088

Middle

Exchange

XNSE - National Stock Exchange Of India

EMAMILTD.NS Stock Analysis

EM

Neutral

Based on Eyestock quantitative analysis, EMAMILTD.NS`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

113/100

High score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-33.0 %

Overvalued

Market cap $B

3.088

Dividend yield

2.60 %

Shares outstanding

439.08 B

Emami Ltd. engages in the marketing and sale of medicinal, cosmetics, and toiletries products. The company is headquartered in Kolkata, West Bengal and currently employs 3,235 full-time employees. The company went IPO on 2006-08-03. The firm is engaged in the business of manufacturing health, beauty and personal care products. The Company’s brands, including BoroPlus, Navratna, Zandu, Fair and Handsome, Kesh King, Mentho plus balm, Dermicool, 7 Oils in One, HE, Diamond Shine, Emami Golden Beauty, Emami Naturally Fair, Emami Emasol and Creme21. The company has a portfolio of over 300 + products based on ayurvedic formulations. Its operations comprise more than 60 countries, including SAARC, MENAP, SEA, Africa, Eastern Europe and the CIS countries. The company provides Ayurvedic Antiseptic Cream, Prickly Heat Powder, Doodh Kesar Body Lotion, Vasocare Herbal Petroleum Jelly, Aloe Vera Gel, Hygiene Range, Cool Oil, Extra Thanda, Gold Ayurvedic Oil and others. The company has manufacturing units in India and abroad to develop products suited to meet the diverse needs and preferences of consumers in different markets.

View Section: Eyestock Rating